
Jeffrey T. Palenik
Examiner (ID: 8947, Phone: (571)270-1966 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 1192 |
| Issued Applications | 644 |
| Pending Applications | 99 |
| Abandoned Applications | 467 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20039088
[patent_doc_number] => 20250177310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-05
[patent_title] => TRIMODAL, PRECISION-TIMED RELEASE TABLET
[patent_app_type] => utility
[patent_app_number] => 18/838775
[patent_app_country] => US
[patent_app_date] => 2023-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18838775
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/838775 | TRIMODAL, PRECISION-TIMED RELEASE TABLET | Feb 14, 2023 | Pending |
Array
(
[id] => 18672879
[patent_doc_number] => 20230310325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => High Surface-Area Lyophilized Compositions Comprising Arsenic For Oral Administration In Patients
[patent_app_type] => utility
[patent_app_number] => 18/160445
[patent_app_country] => US
[patent_app_date] => 2023-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23662
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18160445
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/160445 | Lyophilized compositions comprising arsenic | Jan 26, 2023 | Issued |
Array
(
[id] => 18816012
[patent_doc_number] => 20230390351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => Method for inhibiting infection of SARS-CoV-2 in a Subject
[patent_app_type] => utility
[patent_app_number] => 18/154879
[patent_app_country] => US
[patent_app_date] => 2023-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2244
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18154879
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/154879 | Method for inhibiting infection of SARS-CoV-2 in a subject | Jan 15, 2023 | Issued |
Array
(
[id] => 19845115
[patent_doc_number] => 20250090466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-20
[patent_title] => DRUG DELIVERY COMPOSITIONS AND DEVICES
[patent_app_type] => utility
[patent_app_number] => 18/727296
[patent_app_country] => US
[patent_app_date] => 2023-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17704
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18727296
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/727296 | DRUG DELIVERY COMPOSITIONS AND DEVICES | Jan 8, 2023 | Pending |
Array
(
[id] => 20277627
[patent_doc_number] => 20250302869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-02
[patent_title] => USE OF INHALED NITRIC OXIDE (INO) FOR TREATING PATIENTS WITH PULMONARY HYPERTENSION ASSOCIATED WITH SARCOIDOSIS (PH-SARC)
[patent_app_type] => utility
[patent_app_number] => 18/726314
[patent_app_country] => US
[patent_app_date] => 2023-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5335
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18726314
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/726314 | USE OF INHALED NITRIC OXIDE (INO) FOR TREATING PATIENTS WITH PULMONARY HYPERTENSION ASSOCIATED WITH SARCOIDOSIS (PH-SARC) | Jan 3, 2023 | Pending |
Array
(
[id] => 18433455
[patent_doc_number] => 20230180749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => Stable Botanical Antimicrobial Compositions
[patent_app_type] => utility
[patent_app_number] => 18/092899
[patent_app_country] => US
[patent_app_date] => 2023-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7530
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18092899
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/092899 | Stable Botanical Antimicrobial Compositions | Jan 2, 2023 | Abandoned |
Array
(
[id] => 18359304
[patent_doc_number] => 20230140895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => OPHTHALMIC SUSPENSION COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/086286
[patent_app_country] => US
[patent_app_date] => 2022-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10276
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18086286
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/086286 | Ophthalmic suspension composition | Dec 20, 2022 | Issued |
Array
(
[id] => 18449572
[patent_doc_number] => 20230190848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => P2ET REDUCES COVID SEVERITY BY INHIBITION OF VIRAL REPLICATION, REDUCTION OF PULMONAR FIBROSIS MARKERS AND MODULATION OF INMUNE RESPONSE
[patent_app_type] => utility
[patent_app_number] => 18/069902
[patent_app_country] => US
[patent_app_date] => 2022-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8136
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18069902
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/069902 | P2ET REDUCES COVID SEVERITY BY INHIBITION OF VIRAL REPLICATION, REDUCTION OF PULMONAR FIBROSIS MARKERS AND MODULATION OF INMUNE RESPONSE | Dec 20, 2022 | Pending |
Array
(
[id] => 20644776
[patent_doc_number] => 12599701
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-04-14
[patent_title] => Drug delivery system and methods of using the same
[patent_app_type] => utility
[patent_app_number] => 18/068762
[patent_app_country] => US
[patent_app_date] => 2022-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 5838
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18068762
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/068762 | Drug delivery system and methods of using the same | Dec 19, 2022 | Issued |
Array
(
[id] => 18449355
[patent_doc_number] => 20230190631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => SKIN CARE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/085312
[patent_app_country] => US
[patent_app_date] => 2022-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2604
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18085312
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/085312 | SKIN CARE COMPOSITIONS | Dec 19, 2022 | Pending |
Array
(
[id] => 19784214
[patent_doc_number] => 20250057893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-20
[patent_title] => PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER OR INFLAMMATORY DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/720104
[patent_app_country] => US
[patent_app_date] => 2022-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10753
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18720104
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/720104 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER OR INFLAMMATORY DISEASE | Dec 15, 2022 | Pending |
Array
(
[id] => 19752627
[patent_doc_number] => 20250041192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-06
[patent_title] => IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/718702
[patent_app_country] => US
[patent_app_date] => 2022-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5662
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18718702
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/718702 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Dec 14, 2022 | Pending |
Array
(
[id] => 19629528
[patent_doc_number] => 20240407977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-12
[patent_title] => AQUEOUS LIQUID COSMETIC
[patent_app_type] => utility
[patent_app_number] => 18/717176
[patent_app_country] => US
[patent_app_date] => 2022-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6939
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18717176
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/717176 | AQUEOUS LIQUID COSMETIC | Dec 7, 2022 | Pending |
Array
(
[id] => 20401324
[patent_doc_number] => 12491284
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-09
[patent_title] => Antiseptic wound dressing
[patent_app_type] => utility
[patent_app_number] => 18/062678
[patent_app_country] => US
[patent_app_date] => 2022-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 0
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18062678
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/062678 | Antiseptic wound dressing | Dec 6, 2022 | Issued |
Array
(
[id] => 19722784
[patent_doc_number] => 20250025535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-23
[patent_title] => A COMPOSITION COMPRISING NANOSIZED ACTIVE PHARMACEUTICAL INGREDIENT
[patent_app_type] => utility
[patent_app_number] => 18/710561
[patent_app_country] => US
[patent_app_date] => 2022-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3835
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18710561
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/710561 | A COMPOSITION COMPRISING NANOSIZED ACTIVE PHARMACEUTICAL INGREDIENT | Nov 16, 2022 | Pending |
Array
(
[id] => 20761005
[patent_doc_number] => 20260157977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-06-11
[patent_title] => OCCLUSIVE PLASTER WITH FLEXIBLE BACKING
[patent_app_type] => utility
[patent_app_number] => 18/707337
[patent_app_country] => US
[patent_app_date] => 2022-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1546
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18707337
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/707337 | OCCLUSIVE PLASTER WITH FLEXIBLE BACKING | Nov 3, 2022 | Pending |
Array
(
[id] => 19707060
[patent_doc_number] => 20250017202
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-16
[patent_title] => LONG-LASTING DISINFECTING COMPOSITIONS AND METHODS FOR LONG-LASTING DISINFECTION
[patent_app_type] => utility
[patent_app_number] => 18/700248
[patent_app_country] => US
[patent_app_date] => 2022-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8248
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18700248
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/700248 | LONG-LASTING DISINFECTING COMPOSITIONS AND METHODS FOR LONG-LASTING DISINFECTION | Oct 25, 2022 | Pending |
Array
(
[id] => 18800107
[patent_doc_number] => 11833253
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-12-05
[patent_title] => Extended release pharmaceutical composition of Clozapine
[patent_app_type] => utility
[patent_app_number] => 17/967244
[patent_app_country] => US
[patent_app_date] => 2022-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4840
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17967244
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/967244 | Extended release pharmaceutical composition of Clozapine | Oct 16, 2022 | Issued |
Array
(
[id] => 18323185
[patent_doc_number] => 20230121313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => INTRANASAL ADMINISTRATION OF ESKETAMINE
[patent_app_type] => utility
[patent_app_number] => 17/890039
[patent_app_country] => US
[patent_app_date] => 2022-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 128754
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 226
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17890039
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/890039 | INTRANASAL ADMINISTRATION OF ESKETAMINE | Aug 16, 2022 | Abandoned |
Array
(
[id] => 20756234
[patent_doc_number] => 12648983
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-06-09
[patent_title] => Composition and method having enhanced LSESr to maintain and promote hair health and growth
[patent_app_type] => utility
[patent_app_number] => 17/818013
[patent_app_country] => US
[patent_app_date] => 2022-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 63
[patent_no_of_words] => 14253
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17818013
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/818013 | Composition and method having enhanced LSESr to maintain and promote hair health and growth | Aug 7, 2022 | Issued |